Biomarkers in the Evaluation of Chronic Lung Disease

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Pulmonary HypertensionPulmonary Arterial HypertensionInterstitial Lung Disease
Interventions
OTHER

Blood Gas

Subject will have both venous and arterial blood draws to assess for the bloods content of MIF

OTHER

Pulmonary Exercise Test

Subject will ride exercise bike to assess their pulmonary function level.

OTHER

Spirometry

To assess subjects lung function

OTHER

Breath Condensate Collector

Subject with use breathing apparatus to allow researchers to collect breath condensate to assess level of MIF in breathe condensate.

Trial Locations (1)

11040

Interstitial Lung Disease and Pulmonary Hypertension Programs, New Hyde Park

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER

NCT00926523 - Biomarkers in the Evaluation of Chronic Lung Disease | Biotech Hunter | Biotech Hunter